Mariner, LLC Organon & Co. Transaction History

Mariner, LLC

$55.8 Billion
Q3 2024

A detailed history of Mariner, LLC transactions in Organon & Co. stock. As of the latest transaction made, Mariner, LLC holds 38,680 shares of OGN stock, worth $571,303. This represents 0.0% of its overall portfolio holdings.

Number of Shares

38,680

Previous 37,060 4.37%

Holding current value

$571,303

Previous $767,000 3.65%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$18.65 - $23.03 $30,212 - $37,308	1,620 Added 4.37%	38,680 $739,000
Q2 2024 Aug 13, 2024	BUY	$17.45 - $21.96 $104 - $131	6 Added 0.02%	37,060 $767,000
Q1 2024 May 15, 2024	BUY	$13.78 - $18.8 $91,747 - $125,170	6,658 Added 21.9%	37,054 $696,000
Q4 2023 Feb 14, 2024	SELL	$10.95 - $17.32 $85,147 - $134,680	-7,776 Reduced 20.37%	30,396 $438,000
Q3 2023 Nov 13, 2023	BUY	$16.59 - $23.77 $1,957 - $2,804	118 Added 0.31%	38,172 $662,000
Q2 2023 Aug 11, 2023	BUY	$19.27 - $24.63 $64,361 - $82,264	3,340 Added 9.62%	38,054 $791,000
Q1 2023 May 12, 2023	BUY	$21.42 - $32.08 $85,273 - $127,710	3,981 Added 12.95%	34,714 $816,000
Q4 2022 Feb 14, 2023	BUY	$23.31 - $28.61 $107,575 - $132,035	4,615 Added 17.67%	30,733 $858,000
Q3 2022 Nov 10, 2022	SELL	$23.4 - $34.25 $73,265 - $107,236	-3,131 Reduced 10.7%	26,118 $611,000
Q2 2022 Aug 15, 2022	SELL	$31.66 - $38.9 $28,240 - $34,698	-892 Reduced 2.96%	29,249 $987,000
Q1 2022 May 13, 2022	BUY	$30.45 - $39.36 $130,813 - $169,090	4,296 Added 16.62%	30,141 $1.05 Million
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $458,232 - $593,448	-15,983 Reduced 38.21%	25,845 $787,000
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $1.59 Million - $1.98 Million	-55,551 Reduced 57.05%	41,828 $1.37 Million
Q2 2021 Aug 24, 2021	BUY	$28.45 - $38.0 $2.77 Million - $3.7 Million	97,379 New	97,379 $2.95 Million

Others Institutions Holding OGN

# of Institutions

794

Shares Held

193M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.76B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account